Dr. Steven E. Nissen and I discuss: An Extended Duration Small-interfering RNA Targeting Lipoprotein(a): The Alpaca Phase 2 Trial Of Lepodisiran With 540 Day Follow Up March 30, 2025 2025 | ACC | Cardiology | Trial | Video NissenLepodisiran_ACC_FINALDownload Disclosures: TBD Article Navigation Dr. Pavel Osmancik and I discuss: Catheter Ablation Vs. Risk Factor Modification With Antiarrhythmic Drugs To Treat Atrial Fibrillation – PRAGUE-25 Study Dr. Carolyn Hendrickson and I discuss: The Equiox Study: Evaluating Pulse Oximeter Bias Across A Range Of Skin Pigment In Critically Ill Adults
